Aclaris Therapeutics (ACRS) EPS (Basic) (2014 - 2026)
Aclaris Therapeutics (ACRS) recorded quarterly EPS (Basic) of -$0.15 in Q1 2026, up 6.25% quarter-over-quarter from -$0.16 in Q4 2025, and down 25.0% on a YoY basis from -$0.2 in Q1 2025.
Aclaris Therapeutics (ACRS) EPS (Basic) (2014 - 2026) Analysis & Trends
Aclaris Therapeutics' EPS (Basic) history runs 13 years deep, the most recent figure standing at -$0.15 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 25.0% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.56 (up 64.78% YoY), while the FY2025 annual figure was -$0.53, up 69.01% from the prior year.
- EPS (Basic) was -$0.15 for Q1 2026 at Aclaris Therapeutics, up from -$0.16 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.02 in Q4 2023 to a low of -$1.21 in Q4 2024.
- Historically, EPS (Basic) has averaged -$0.29 across 5 years, with a median of -$0.24 in 2024.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) surged 95.12% in 2023, then sank 5950.0% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.41 in 2022, then soared by 95.12% to -$0.02 in 2023, then tumbled by 5950.0% to -$1.21 in 2024, then jumped by 86.78% to -$0.16 in 2025, then climbed by 6.25% to -$0.15 in 2026.
- The last three EPS (Basic) figures came in at -$0.15 (Q1 2026), -$0.16 (Q4 2025), and -$0.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Aclaris Therapeutics | 580.93 Mn | 580.93 Mn | 1.60 Mn | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.12 |
| Dec 31, 2024 | -1.21 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.15 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -0.42 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -0.41 |
| Sep 30, 2022 | -0.30 |
| Jun 30, 2022 | -0.31 |
| Mar 31, 2022 | -0.31 |
| Dec 31, 2021 | -0.37 |
| Sep 30, 2021 | -0.35 |
| Jun 30, 2021 | -0.34 |